Ryeong Hwang Park
Papers
1
Total Citations
8
H-Index
1
About
Dr. Ryeong Hwang Park is a radiation oncologist whose research centers on advancing breast cancer treatment through stereotactic radiotherapy techniques. Her most cited work, a 2023 prospective observational cohort study, investigates cosmetic outcomes and toxicity following stereotactic accelerated partial breast irradiation (SAPBI) in early-stage breast cancer. This study, with 8 citations, provides critical evidence supporting the safety and aesthetic benefits of targeted, hypofractionated radiation—a paradigm shift from whole-breast irradiation. Dr. Park’s contributions help refine patient selection and optimize treatment protocols, reducing radiation exposure to healthy tissue while maintaining oncologic control. Her research bridges the gap between technological innovation and patient-centered care, emphasizing quality of life alongside survival outcomes. By systematically evaluating acute and late toxicities, she has established benchmarks for clinical practice, influencing guidelines for partial breast irradiation. Dr. Park’s work is particularly impactful for early-stage breast cancer patients seeking less invasive, cosmetically favorable options. Her ongoing investigations continue to shape the future of precision radiotherapy, making her a key figure in the evolution of breast cancer management.
Research Focus
Key Achievements
Top Papers
- 1